Pale Fire Capital SE’s Palisade Bio PALI Stock Holding History

Pale Fire Capital SE’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Hold	111,410	–	–	0.02%	61
2026 Q1	$195K	Buy	111,410 +40,700	+58%	+$74K	0.02%	56
2025 Q4	$166K	Buy	+70,710	New	+$136K	0.01%	56

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Pale Fire Capital SE's PALI Position: Q2 2026 in Review

Pale Fire Capital SE held its Palisade Bio (PALI) position steady in Q2 2026 at 111,410 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #61.

Pale Fire Capital SE first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Pale Fire Capital SE held 111,410 shares of Palisade Bio worth $233K as of Q2 2026.
Pale Fire Capital SE left its Palisade Bio share count unchanged in Q2 2026.
Palisade Bio made up 0.02% of Pale Fire Capital SE's portfolio in Q2 2026, its #61 holding.
Pale Fire Capital SE first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.